If the preceding year acted as an introduction, the U.S. government is gearing up to revise the regulations concerning the utilization of artificial intelligence in the healthcare sector in 2024.
In a recent move, President Joe Biden issued a comprehensive directive targeting AI within national health agencies. Simultaneously, members of Congress have committed to enhancing supervision and crafting new policies, while a multitude of AI experts, both from within and outside the industry, have expressed apprehensions regarding the urgent necessity for standardized protocols.
The heightened focus has been triggered by the rapid advancement of relational AI tools such as ChatGPT. Consequently, developers of various predictive models may face requests to validate their safety, reliability, and impartiality for the first time, along with providing insights into the methodologies employed in their development and testing processes.
